Parathyroid hormone mediates bone growth through the regulation of osteoblast proliferation and differentiation
- 30 April 2008
- journal article
- Published by Elsevier BV in Bone
- Vol. 42 (4), 806-818
- https://doi.org/10.1016/j.bone.2007.11.017
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Effects Of a One-Month Treatment With PTH(1–34) on Bone Formation on Cancellous, Endocortical, and Periosteal Surfaces of the Human IliumJournal of Bone and Mineral Research, 2007
- Co-Treatment of PTH With Osteoprotegerin or Alendronate Increases Its Anabolic Effect on the Skeleton of Oophorectomized MiceJournal of Bone and Mineral Research, 2007
- Effects of low-dose, intermittent treatment with recombinant human parathyroid hormone (1–34) on chondrogenesis in a model of experimental fracture healingBone, 2005
- Anabolic actions of PTH (1-34): Use of a novel tissue engineering model to investigate temporal effects on boneBone, 2005
- Bisphosphonates Pamidronate and Zoledronic Acid Stimulate Osteoprotegerin Production by Primary Human OsteoblastsBiochemical and Biophysical Research Communications, 2002
- Anabolic or Catabolic Responses of MC3T3-E1 Osteoblastic Cells to Parathyroid Hormone Depend on Time and Duration of TreatmentJournal of Bone and Mineral Research, 1999
- Alendronate Does Not Block the Anabolic Effect of PTH in Postmenopausal Osteoporotic WomenJournal of Bone and Mineral Research, 1998
- Inhibition of antigen-presenting cell function by alendronate in vitroJournal of Bone and Mineral Research, 1995
- Modulation of osteogenic cell ultrastructure by RS-23581, an analog of human parathyroid hormone (PTH)-related peptide-(1-34), and bovine PTH- (1-34)Endocrinology, 1995
- Bisphosphonates in vitro specifically inhibit, among the hematopoietic series, the development of the mouse mononuclear phagocyte lineageJournal of Bone and Mineral Research, 1990